"Benzylidene Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds containing the PhCH= radical.
| Descriptor ID |
D001597
|
| MeSH Number(s) |
D02.455.426.559.389.150
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Benzylidene Compounds".
Below are MeSH descriptors whose meaning is more specific than "Benzylidene Compounds".
This graph shows the total number of publications written about "Benzylidene Compounds" by people in this website by year, and whether "Benzylidene Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Benzylidene Compounds" by people in Profiles.
-
Discovery of benzo[cd]indol-2-one and benzylidene-thiazolidine-2,4-dione as new classes of NLRP3 inflammasome inhibitors via ER-? structure based virtual screening. Bioorg Chem. 2020 01; 95:103500.
-
Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 2018 08; 28(8):862-864.
-
Crosstalk between histone modifications indicates that inhibition of arginine methyltransferase CARM1 activity reverses HIV latency. Nucleic Acids Res. 2017 Sep 19; 45(16):9348-9360.
-
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma. J Ovarian Res. 2017 Aug 07; 10(1):53.
-
Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses. Clin Cancer Res. 2014 Jun 15; 20(12):3174-86.
-
Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation. J Allergy Clin Immunol. 2013 Apr; 131(4):1194-203, 1203.e1-14.
-
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators. J Med Chem. 2003 Sep 11; 46(19):4104-12.